Published in J Cell Sci on August 05, 2008
Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis. Sci Transl Med (2014) 1.67
N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic. J Cell Biol (2009) 1.54
Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures. Am J Physiol Lung Cell Mol Physiol (2009) 1.37
Novel human bronchial epithelial cell lines for cystic fibrosis research. Am J Physiol Lung Cell Mol Physiol (2008) 1.24
Pharmacological rescue of the mutant cystic fibrosis transmembrane conductance regulator (CFTR) detected by use of a novel fluorescence platform. Mol Med (2012) 1.15
Identification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step. EMBO J (2013) 1.14
Constitutive internalization of the leucine-rich G protein-coupled receptor-5 (LGR5) to the trans-Golgi network. J Biol Chem (2013) 0.97
A chaperone trap contributes to the onset of cystic fibrosis. PLoS One (2012) 0.93
Purification of CFTR for mass spectrometry analysis: identification of palmitoylation and other post-translational modifications. Protein Eng Des Sel (2011) 0.89
Regulation of GIP and GLP1 receptor cell surface expression by N-glycosylation and receptor heteromerization. PLoS One (2012) 0.88
Three charged amino acids in extracellular loop 1 are involved in maintaining the outer pore architecture of CFTR. J Gen Physiol (2014) 0.86
Cell surface rescue of kidney anion exchanger 1 mutants by disruption of chaperone interactions. J Biol Chem (2010) 0.86
Comparative processing and function of human and ferret cystic fibrosis transmembrane conductance regulator. J Biol Chem (2012) 0.84
N-glycosylation-dependent control of functional expression of background potassium channels K2P3.1 and K2P9.1. J Biol Chem (2012) 0.84
A stable human-cell system overexpressing cystic fibrosis transmembrane conductance regulator recombinant protein at the cell surface. Mol Biotechnol (2015) 0.83
Alteration of CFTR transmembrane span integration by disease-causing mutations. Mol Biol Cell (2011) 0.82
FK506 binding protein 8 peptidylprolyl isomerase activity manages a late stage of cystic fibrosis transmembrane conductance regulator (CFTR) folding and stability. J Biol Chem (2012) 0.82
Regulation of ENaC biogenesis by the stress response protein SERP1. Pflugers Arch (2012) 0.81
Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of Ito channel complex. Pflugers Arch (2010) 0.80
C-terminus glycans with critical functional role in the maturation of secretory glycoproteins. PLoS One (2011) 0.79
A survey of detergents for the purification of stable, active human cystic fibrosis transmembrane conductance regulator (CFTR). Biochim Biophys Acta (2014) 0.78
Nephrin missense mutations: induction of endoplasmic reticulum stress and cell surface rescue by reduction in chaperone interactions. Physiol Rep (2013) 0.77
Restoration of R117H CFTR folding and function in human airway cells through combination treatment with VX-809 and VX-770. Am J Physiol Lung Cell Mol Physiol (2016) 0.77
Development of CFTR Structure. Front Pharmacol (2012) 0.77
Hypertension-linked mutation of α-adducin increases CFTR surface expression and activity in HEK and cultured rat distal convoluted tubule cells. PLoS One (2012) 0.77
S-palmitoylation regulates biogenesis of core glycosylated wild-type and F508del CFTR in a post-ER compartment. Biochem J (2014) 0.76
Attenuation of Phosphorylation-dependent Activation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Disease-causing Mutations at the Transmission Interface. J Biol Chem (2016) 0.75
Trafficking and function of the cystic fibrosis transmembrane conductance regulator: a complex network of posttranslational modifications. Am J Physiol Lung Cell Mol Physiol (2016) 0.75
Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell (1990) 9.21
Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature (1992) 8.47
Intracellular functions of N-linked glycans. Science (2001) 8.39
Degradation of CFTR by the ubiquitin-proteasome pathway. Cell (1995) 7.88
Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell (1995) 5.61
Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature (1992) 5.45
Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell (2006) 5.01
Well-differentiated human airway epithelial cell cultures. Methods Mol Med (2005) 4.66
Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Invest (2005) 4.19
Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell (2006) 3.73
CFTR function and prospects for therapy. Annu Rev Biochem (2008) 3.71
Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. Am J Physiol Lung Cell Mol Physiol (2006) 3.59
Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. J Biol Chem (1994) 3.43
EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin. Science (2003) 3.28
Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. Science (1991) 3.12
Protein glucosylation and its role in protein folding. Annu Rev Biochem (2000) 3.09
Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J (1994) 2.93
Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation. J Cell Biol (2006) 2.76
Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes. J Cell Biol (2004) 2.74
Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science (2004) 2.39
Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (1994) 2.27
Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol Cell Biol (1991) 2.25
Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. Mol Biol Cell (2004) 2.21
The ER-Golgi intermediate compartment (ERGIC): in search of its identity and function. J Cell Sci (2006) 2.21
A role for N-glycanase in the cytosolic turnover of glycoproteins. EMBO J (2003) 2.18
The number and location of glycans on influenza hemagglutinin determine folding and association with calnexin and calreticulin. J Cell Biol (1997) 2.14
Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol Biol Cell (2005) 2.13
Novel mannosidase inhibitor blocking conversion of high mannose to complex oligosaccharides. Nature (1984) 2.10
The lectin ERGIC-53 is a cargo transport receptor for glycoproteins. Nat Cell Biol (1999) 1.82
Regulation of MHC class I transport by the molecular chaperone, calnexin (p88, IP90). Science (1994) 1.79
Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells. Nat Med (2002) 1.75
Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I. J Biol Chem (1990) 1.72
Contrasting functions of calreticulin and calnexin in glycoprotein folding and ER quality control. Mol Cell (2004) 1.62
Quality control in the secretory pathway: the role of calreticulin, calnexin and BiP in the retention of glycoproteins with C-terminal truncations. Mol Biol Cell (1997) 1.59
Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin. Mol Cell Biol (2005) 1.58
Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis. Trends Pharmacol Sci (2007) 1.55
Endoplasmic reticulum retention, degradation, and aggregation of olfactory G-protein coupled receptors. Traffic (2003) 1.54
Association of calnexin with mutant peripheral myelin protein-22 ex vivo: a basis for "gain-of-function" ER diseases. Proc Natl Acad Sci U S A (2002) 1.50
Regulation of CFTR ion channel gating by MgATP. FEBS Lett (1998) 1.46
Mapping of cystic fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion. J Biol Chem (1994) 1.42
Functional significance of the beta-subunit for heterodimeric P-type ATPases. J Exp Biol (1995) 1.37
N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane. Biochemistry (2005) 1.33
Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism. Proc Natl Acad Sci U S A (2000) 1.32
Glycosylation is important for cell surface expression of the water channel aquaporin-2 but is not essential for tetramerization in the endoplasmic reticulum. J Biol Chem (2003) 1.32
Enhanced epithelial gene transfer by modulation of tight junctions with sodium caprate. Am J Respir Cell Mol Biol (2000) 1.31
Single, context-specific glycans can target misfolded glycoproteins for ER-associated degradation. J Cell Biol (2005) 1.31
Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression. Mol Biol Cell (2003) 1.29
N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein. J Biol Chem (1993) 1.28
Importance of carbohydrate positioning in the recognition of mutated CPY for ER-associated degradation. J Cell Sci (2005) 1.27
Cystic fibrosis transmembrane conductance regulator degradation depends on the lectins Htm1p/EDEM and the Cdc48 protein complex in yeast. Mol Biol Cell (2004) 1.25
EDEM is involved in retrotranslocation of ricin from the endoplasmic reticulum to the cytosol. Mol Biol Cell (2006) 1.23
Regulation of the stability of P-glycoprotein by ubiquitination. Mol Pharmacol (2004) 1.19
Yeast N-glycanase distinguishes between native and non-native glycoproteins. EMBO Rep (2004) 1.18
Evidence against the rescue of defective DeltaF508-CFTR cellular processing by curcumin in cell culture and mouse models. J Biol Chem (2004) 1.16
The H,K-ATPase beta subunit as a model to study the role of N-glycosylation in membrane trafficking and apical sorting. J Biol Chem (2004) 1.11
Asparagine-linked glycosylation: specificity and function of oligosaccharyl transferase. Bioorg Med Chem (1995) 1.09
Functional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression system. J Membr Biol (2000) 1.09
SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis. Am J Respir Cell Mol Biol (2005) 1.08
Maintaining low Ca2+ level in the endoplasmic reticulum restores abnormal endogenous F508del-CFTR trafficking in airway epithelial cells. Traffic (2006) 1.07
Activity of the renal Na+-K+-2Cl- cotransporter is reduced by mutagenesis of N-glycosylation sites: role for protein surface charge in Cl- transport. Am J Physiol Renal Physiol (2005) 1.05
Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus. Biochemistry (2001) 1.05
Rescue of folding defects in ABC transporters using pharmacological chaperones. J Bioenerg Biomembr (2005) 1.05
Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alpha-glucosidase inhibitor miglustat. FEBS Lett (2006) 1.04
Calnexin retains unassembled major histocompatibility complex class I free heavy chains in the endoplasmic reticulum. J Exp Med (1994) 1.03
Thapsigargin or curcumin does not promote maturation of processing mutants of the ABC transporters, CFTR, and P-glycoprotein. Biochem Biophys Res Commun (2004) 0.99
Calnexin regulated gonadotropin-releasing hormone receptor plasma membrane expression. J Mol Endocrinol (2006) 0.98
Misfolding of glycoproteins is a prerequisite for peptide: N-glycanase mediated deglycosylation. FEBS Lett (2005) 0.98
The MRH protein Erlectin is a member of the endoplasmic reticulum synexpression group and functions in N-glycan recognition. J Biol Chem (2006) 0.97
N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway. Biochemistry (2007) 0.97
Castanospermine inhibits glucosidase I and glycoprotein secretion in human hepatoma cells. Biochem J (1985) 0.97
Specific N-glycans direct apical delivery of transmembrane, but not soluble or glycosylphosphatidylinositol-anchored forms of endolyn in Madin-Darby canine kidney cells. Mol Biol Cell (2003) 0.97
The role of glycosylation in ionotropic glutamate receptor ligand binding, function, and trafficking. Cell Mol Life Sci (2000) 0.93
Absence of N-linked glycosylation does not affect plasma membrane localization of breast cancer resistance protein (BCRP/ABCG2). Cancer Chemother Pharmacol (2005) 0.91
Curcumin does not stimulate cAMP-mediated chloride transport in cystic fibrosis airway epithelial cells. Biochem Biophys Res Commun (2004) 0.91
Role of calnexin in the ER quality control and productive folding of CFTR; differential effect of calnexin knockout on wild-type and DeltaF508 CFTR. Biochim Biophys Acta (2008) 0.90
Hypothesis: a glycoprotein-degradation complex formed by protein-protein interaction involves cytoplasmic peptide:N-glycanase. Biochem Biophys Res Commun (2003) 0.89
VIPL, a VIP36-like membrane protein with a putative function in the export of glycoproteins from the endoplasmic reticulum. Exp Cell Res (2003) 0.89
Inhibition of N-linked glycosylation of P-glycoprotein by tunicamycin results in a reduced multidrug resistance phenotype. Br J Cancer (1995) 0.88
Curcumin enhances cystic fibrosis transmembrane regulator expression by down-regulating calreticulin. Biochem Biophys Res Commun (2006) 0.87
Purification and characterization of N-glycosylation mutant mouse and human P-glycoproteins expressed in Pichia pastoris cells. Arch Biochem Biophys (2001) 0.87
Polarized membrane distribution of potassium-dependent ion pumps in epithelial cells: different roles of the N-glycans of their beta subunits. Cell Biochem Biophys (2007) 0.87
Calnexin Delta 185-520 partially reverses the misprocessing of the Delta F508 cystic fibrosis transmembrane conductance regulator. FEBS Lett (2002) 0.85
Glycosylation status of endogenous CFTR does not affect cAMP-stimulated Cl- secretion in epithelial cells. Am J Physiol (1993) 0.85
Biogenesis of alpha6beta4 integrin in a human colonic adenocarcinoma cell line involvement of calnexin. Eur J Biochem (1999) 0.84
Calnexin associates with Shaker K+ channel protein but is not involved in quality control of subunit folding or assembly. Receptors Channels (1999) 0.82
Glycosylation affects the rate of traffic of the Shaker potassium channel through the secretory pathway. Biochemistry (2002) 0.79
Clusters of VIP-36-positive vesicles between endoplasmic reticulum and Golgi apparatus in GH3 cells. Cell Struct Funct (2003) 0.77
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med (2013) 8.76
Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell (2006) 5.01
Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc Natl Acad Sci U S A (2008) 3.08
Methods for obtaining and analyzing whole chloroplast genome sequences. Methods Enzymol (2005) 2.86
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat Chem Biol (2009) 2.70
The Chlamydomonas reinhardtii plastid chromosome: islands of genes in a sea of repeats. Plant Cell (2002) 2.36
Identifying the basal angiosperm node in chloroplast genome phylogenies: sampling one's way out of the Felsenstein zone. Mol Biol Evol (2005) 2.23
Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. Mol Biol Cell (2004) 2.21
The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover. J Biol Chem (2002) 2.20
Expression pattern shifts following duplication indicative of subfunctionalization and neofunctionalization in regulatory genes of Arabidopsis. Mol Biol Evol (2005) 2.18
Domain interdependence in the biosynthetic assembly of CFTR. J Mol Biol (2006) 2.17
Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol Biol Cell (2005) 2.13
CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium. PLoS Biol (2009) 2.10
The China National Stroke Registry for patients with acute cerebrovascular events: design, rationale, and baseline patient characteristics. Int J Stroke (2011) 1.90
F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive. Biochim Biophys Acta (2006) 1.87
Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J (2011) 1.79
COPII-dependent export of cystic fibrosis transmembrane conductance regulator from the ER uses a di-acidic exit code. J Cell Biol (2004) 1.70
An expanded biological repertoire for Ins(3,4,5,6)P4 through its modulation of ClC-3 function. Curr Biol (2008) 1.62
Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating. J Biol Chem (2008) 1.62
EST clustering error evaluation and correction. Bioinformatics (2004) 1.54
Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR). J Biol Chem (2004) 1.54
Syntheses and properties of a series of cationic water-soluble phthalocyanines. J Med Chem (2008) 1.51
Non-conventional trafficking of the cystic fibrosis transmembrane conductance regulator through the early secretory pathway. J Biol Chem (2002) 1.50
Association of interleukin-1 gene cluster polymorphisms with ischemic stroke in a Chinese population. Neurol India (2006) 1.45
F-wave latencies in patients with diabetes mellitus. Muscle Nerve (2014) 1.42
Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures. Am J Physiol Lung Cell Mol Physiol (2009) 1.37
Gene capture prediction and overlap estimation in EST sequencing from one or multiple libraries. BMC Bioinformatics (2005) 1.35
The role of cystic fibrosis transmembrane conductance regulator phenylalanine 508 side chain in ion channel gating. J Physiol (2006) 1.34
Chemical and biological folding contribute to temperature-sensitive DeltaF508 CFTR trafficking. Traffic (2008) 1.34
CFTR (ABCC7) is a hydrolyzable-ligand-gated channel. Pflugers Arch (2006) 1.32
Regulatory insertion removal restores maturation, stability and function of DeltaF508 CFTR. J Mol Biol (2010) 1.31
Direct interaction with filamins modulates the stability and plasma membrane expression of CFTR. J Clin Invest (2007) 1.29
The PDZ-binding chloride channel ClC-3B localizes to the Golgi and associates with cystic fibrosis transmembrane conductance regulator-interacting PDZ proteins. J Biol Chem (2002) 1.28
The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon. Gastroenterology (2004) 1.25
Cystic fibrosis transmembrane conductance regulator degradation depends on the lectins Htm1p/EDEM and the Cdc48 protein complex in yeast. Mol Biol Cell (2004) 1.25
Restoration of domain folding and interdomain assembly by second-site suppressors of the DeltaF508 mutation in CFTR. FASEB J (2010) 1.18
Allosteric modulation balances thermodynamic stability and restores function of ΔF508 CFTR. J Mol Biol (2012) 1.18
Correctors of ΔF508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein. FASEB J (2012) 1.17
Misassembled mutant DeltaF508 CFTR in the distal secretory pathway alters cellular lipid trafficking. J Cell Sci (2007) 1.15
Architecture of the cystic fibrosis transmembrane conductance regulator protein and structural changes associated with phosphorylation and nucleotide binding. J Struct Biol (2009) 1.13
An organic white light-emitting fluorophore. J Am Chem Soc (2006) 1.11
SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis. Am J Respir Cell Mol Biol (2005) 1.08
Regulation of the epithelial Na+ channel and airway surface liquid volume by serine proteases. Pflugers Arch (2010) 1.08
Diminished self-chaperoning activity of the DeltaF508 mutant of CFTR results in protein misfolding. PLoS Comput Biol (2008) 1.08
Antibodies for CFTR studies. J Cyst Fibros (2004) 1.06
Relationship between nucleotide binding and ion channel gating in cystic fibrosis transmembrane conductance regulator. J Physiol (2009) 1.06
The cystic fibrosis transmembrane conductance regulator (CFTR): three-dimensional structure and localization of a channel gate. J Biol Chem (2011) 1.02
Computational studies reveal phosphorylation-dependent changes in the unstructured R domain of CFTR. J Mol Biol (2008) 1.01
Synthesis and cellular studies of porphyrin-cobaltacarborane conjugates. Bioconjug Chem (2005) 1.01
Stimulatory and inhibitory protein kinase C consensus sequences regulate the cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A (2003) 1.00
Biochemical methods to assess CFTR expression and membrane localization. J Cyst Fibros (2004) 1.00
Seminaphthofluorones are a family of water-soluble, low molecular weight, NIR-emitting fluorophores. Proc Natl Acad Sci U S A (2008) 0.99
Novel regulation of cystic fibrosis transmembrane conductance regulator (CFTR) channel gating by external chloride. J Biol Chem (2004) 0.99
Nucleoside triphosphate pentose ring impact on CFTR gating and hydrolysis. FEBS Lett (2002) 0.98
Fabrication of silicon/polymer composite nanopost arrays and their sensing applications. Small (2011) 0.96
Peptide-mediated cell transport of water soluble porphyrin conjugates. J Med Chem (2006) 0.96
Synthesis and characterization of positively charged porphyrin-peptide conjugates. Bioconjug Chem (2005) 0.96
ATP binding to the first nucleotide-binding domain of multidrug resistance protein MRP1 increases binding and hydrolysis of ATP and trapping of ADP at the second domain. J Biol Chem (2001) 0.95
Mg2+ -dependent ATP occlusion at the first nucleotide-binding domain (NBD1) of CFTR does not require the second (NBD2). Biochem J (2008) 0.95
Domain location within the cystic fibrosis transmembrane conductance regulator protein investigated by electron microscopy and gold labelling. Biochim Biophys Acta (2010) 0.93
ATP binding, not hydrolysis, at the first nucleotide-binding domain of multidrug resistance-associated protein MRP1 enhances ADP.Vi trapping at the second domain. J Biol Chem (2002) 0.92
Role of individual R domain phosphorylation sites in CFTR regulation by protein kinase A. Biochim Biophys Acta (2009) 0.92
Functional analysis of the C-terminal boundary of the second nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator and structural implications. Biochem J (2002) 0.91